Based on a comprehensive genomic analysis, genetic alterations of the PI3K/Akt/mTOR pathway (including PIK3CA, PTEN, AKT2, AKT3, RICTOR, and MTOR genes) are present in 36% of the SCLC patients [30]. The gene discussed is MTOR; the disease is small cell lung carcinoma.